Status:
RECRUITING
3D Printed Custom Applicators for HDR BT (DISCO)
Lead Sponsor:
Royal North Shore Hospital
Collaborating Sponsors:
Northern Sydney and Central Coast Area Health Service
Conditions:
Gynecologic Cancer
Endometrial Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Intracavitary brachytherapy for gynaecological cancer currently use cylinder-type applicators or custom wax moulds to place a radioactive source in close proximity to the treatment area and provide hi...
Detailed Description
Intracavitary brachytherapy for gynaecological cancer currently use cylinder-type applicators or custom wax moulds to place a radioactive source in close proximity to the treatment area and provide hi...
Eligibility Criteria
Inclusion
- Able to give informed consent
- Patients indicated for intracavitary brachytherapy
- FIGO stage I-IVA
- ECOG 0-2
- Primary endometrial cancer, primary vaginal cancer, primary vulva cancer, recurrent gynaecological cancer
Exclusion
- Pregnancy
- Patients contraindicated for brachytherapy
- Inflammatory bowel disease/history of adhesions/bowel obstruction
- Renal transplant/horseshoe kidney
- Patients with significant LVSI or pelvic sidewall invasion
- Patients requiring interstitial brachytherapy implants
Key Trial Info
Start Date :
November 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06432478
Start Date
November 24 2023
End Date
September 1 2028
Last Update
February 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal North Shore Hospital
St Leonards, New South Wales, Australia, 2067